New data looks at how the rapid implementation of cystic fibrosis telemedicine was successful for monitoring lung function and identifying exacerbations during the COVID-19 pandemic.
The care model also enabled monitoring of BMI and decreased use of antibiotics.
“Telemedicine increases access to care for adults with CF living in regions remote to a cystic fibrosis specialty center, but routine use of telemedicine did not gain widespread traction until the COVID-19 pandemic,” Lindsay A.L. Somerville, MD, pulmonologist in the division of pulmonary and critical care at the University of Virginia, Charlottesville, and colleagues wrote. “In March of 2020, the adult cystic fibrosis team at the University of Virginia rapidly transitioned from in-person clinical encounters to a CF care model that included interdisciplinary telemedicine using the HIPAA-compliant video communication.”
Somerville and colleagues reported clinical outcomes of the care model that included interdisciplinary telemedicine as compared with in-person care for patients with cystic fibrosis during the pandemic.
Get the full story at healio.com.
cystic fibrosis telemedicine
Go To Source For Respiratory Therapy Coverage
RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.
Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.
